- $575.74m
- $440.92m
- $268.72m
- 87
- 30
- 85
- 75
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 85 | 93.1 | 141 | 271 | 269 |
Cost of Revenue | |||||
Gross Profit | 32.7 | 37.9 | 61.2 | 113 | 85.3 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 79.8 | 84.7 | 116 | 207 | 231 |
Operating Profit | 5.19 | 8.38 | 25.2 | 63.8 | 37.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.93 | 9.15 | 25.7 | 63.8 | 41.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.57 | 7.29 | 20.3 | 49.4 | 32.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.57 | 7.29 | 20.3 | 49.4 | 32.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.57 | 7.29 | 20.3 | 49.4 | 32.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.339 | 0.535 | 1.47 | 3.55 | 2.17 |